A2Z / USDT

A2Z / USDC

IQ / USDT

NTRN / TRY

NTRN / USDT

DUSK / BTC

ENSO / BNB

PROM / USDT

DUSK / USDT

KAITO / TRY

FORTH / USDT

SXP / USDT

FLOW / USDT

SXP / TRY

SIGN / FDUSD

DENT / TRY

DENT / USDT

SIGN / USDT

SIGN / USDC

SIGN / TRY

NINTEC SYSTEMS LIMITED

GOCL CORPORATION LIMITED

MAHALAXMI RUBTECH LIMITED

DIENSTEN TECH LIMITED

MARVEL DECOR LIMITED

BLS INTL SERVS LTD

PRECISION CAMSHAFTS LTD.

SUNREST LIFESCIENCE LTD

DENTA WATER N INFRA SOL L

KANPUR PLASTIPACK LIMITED

KILITCH DRUGS INDIA LTD

PRABHA ENERGY LTD

FINO PAYMENTS BANK LTD

INNOVISION LIMITED

SACHEEROME LIMITED

NIDAN LABS AND HEALTH LTD

ATAM VALVES LIMITED

LLOYDS LUXURIES LIMITED

OPTIVALUE TEK CONSULT LTD

RADIOWALLA NETWORK LTD

Click here to get full coverage on Vegas Golden Knights Sign Goaltender Pavel Moysevich to Three-Year, Entry-Level Contract - NHL.com

Vegas Golden Knights Sign Goaltender Pavel Moysevich to Three-Year, Entry-Level Contract  NHL.com

Vegas Golden Knights Sign Goaltender Pavel Moysevich to Three-Year, Entry-Level Contract - NHL.com

Click here to get full coverage on Networks in action: strategic milestones of BIREME, VHL and RIPSA in March - Pan American Health Organization (PAHO)

Networks in action: strategic milestones of BIREME, VHL and RIPSA in March  Pan American Health Organization (PAHO)

Networks in action: strategic milestones of BIREME, VHL and RIPSA in March - Pan American Health Organization (PAHO)

Click here to get full coverage on VHL: Revenue growth accelerates through US expansion, EMR efficiencies, and stacked reimbursement - TradingView

VHL: Revenue growth accelerates through US expansion, EMR efficiencies, and stacked reimbursement  TradingView

VHL: Revenue growth accelerates through US expansion, EMR efficiencies, and stacked reimbursement - TradingView

Click here to get full coverage on Belzutifan Maintains High, Durable Responses in VHL Disease–Associated Neoplasms At 5 Years - OncLive

Belzutifan Maintains High, Durable Responses in VHL Disease–Associated Neoplasms At 5 Years  OncLive

Belzutifan Maintains High, Durable Responses in VHL Disease–Associated Neoplasms At 5 Years - OncLive

Click here to get full coverage on HIFα isoform specific activities drive cell-type specificity of VHL -associated oncogenesis - Nature

HIFα isoform specific activities drive cell-type specificity of VHL -associated oncogenesis  Nature

HIFα isoform specific activities drive cell-type specificity of VHL -associated oncogenesis - Nature

Click here to get full coverage on Case Report: von Hippel-Lindau (VHL) disease: a young female presenting with multiple organ tumors - Frontiers

Case Report: von Hippel-Lindau (VHL) disease: a young female presenting with multiple organ tumors  Frontiers

Case Report: von Hippel-Lindau (VHL) disease: a young female presenting with multiple organ tumors - Frontiers

Click here to get full coverage on ASCO 2025: Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor Belzutifan in Von Hippel-Lindau (VHL) Disease–associated Neoplasms: 5-Year Follow-up of the Phase 2 LITESPARK-004 Study - UroToday

ASCO 2025: Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor Belzutifan in Von Hippel-Lindau (VHL) Disease–associated Neoplasms: 5-Year Follow-up of the Phase 2 LITESPARK-004 Study  UroToday

ASCO 2025: Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor Belzutifan in Von Hippel-Lindau (VHL) Disease–associated Neoplasms: 5-Year Follow-up of the Phase 2 LITESPARK-004 Study - UroToday

Click here to get full coverage on Vitasora Health Limited's (ASX:VHL) Path To Profitability - Yahoo Finance

Vitasora Health Limited's (ASX:VHL) Path To Profitability  Yahoo Finance

Vitasora Health Limited's (ASX:VHL) Path To Profitability - Yahoo Finance

Click here to get full coverage on Bifurcate Regulation of Hematopoietic Homeostasis and Bone Osteogenesis by VHL-HIF2α-Controlled Adipocyte Function - Wiley

Bifurcate Regulation of Hematopoietic Homeostasis and Bone Osteogenesis by VHL-HIF2α-Controlled Adipocyte Function  Wiley

Bifurcate Regulation of Hematopoietic Homeostasis and Bone Osteogenesis by VHL-HIF2α-Controlled Adipocyte Function - Wiley

Click here to get full coverage on Islanders Prospect Daniil Prokhorov Named VHL Rookie of the Week - Isles In The Sound

Islanders Prospect Daniil Prokhorov Named VHL Rookie of the Week  Isles In The Sound

Islanders Prospect Daniil Prokhorov Named VHL Rookie of the Week - Isles In The Sound

Click here to get full coverage on VHL: Revenue growth accelerates through policy tailwinds, automation, and expanded patient volume - TradingView

VHL: Revenue growth accelerates through policy tailwinds, automation, and expanded patient volume  TradingView

VHL: Revenue growth accelerates through policy tailwinds, automation, and expanded patient volume - TradingView

Click here to get full coverage on Determination of key functional structures of an amorphous VHL-based SMARCA2 PROTAC - Nature

Determination of key functional structures of an amorphous VHL-based SMARCA2 PROTAC  Nature

Determination of key functional structures of an amorphous VHL-based SMARCA2 PROTAC - Nature

Click here to get full coverage on SUO 2025: LITESPARK-004: 5-Year Follow-up of the Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor Belzutifan in Von Hippel-Lindau (VHL) Disease–associated Neoplasms - UroToday

SUO 2025: LITESPARK-004: 5-Year Follow-up of the Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor Belzutifan in Von Hippel-Lindau (VHL) Disease–associated Neoplasms  UroToday

SUO 2025: LITESPARK-004: 5-Year Follow-up of the Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor Belzutifan in Von Hippel-Lindau (VHL) Disease–associated Neoplasms - UroToday

Click here to get full coverage on Chemically-induced degradation of the endoplasmic-reticulum stress sensor IRE1 by a VHL-recruiting chimera - Nature

Chemically-induced degradation of the endoplasmic-reticulum stress sensor IRE1 by a VHL-recruiting chimera  Nature

Chemically-induced degradation of the endoplasmic-reticulum stress sensor IRE1 by a VHL-recruiting chimera - Nature

Click here to get full coverage on VHL: Revenue and patient growth accelerate as new AI-driven EMR system launches for greater efficiency - TradingView

VHL: Revenue and patient growth accelerate as new AI-driven EMR system launches for greater efficiency  TradingView

VHL: Revenue and patient growth accelerate as new AI-driven EMR system launches for greater efficiency - TradingView

Click here to get full coverage on A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1 - Nature

A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1  Nature

A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1 - Nature

Click here to get full coverage on In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID - Nature

In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID  Nature

In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID - Nature

Click here to get full coverage on Stick it with VHL - Nature

Stick it with VHL - Nature

Click here to get full coverage on Molecular dynamics reveal potential effects of novel VHL variants on VHL-Elongin C binding in ccRCC patients from Eastern India - Nature

Molecular dynamics reveal potential effects of novel VHL variants on VHL-Elongin C binding in ccRCC patients from Eastern India  Nature

Molecular dynamics reveal potential effects of novel VHL variants on VHL-Elongin C binding in ccRCC patients from Eastern India - Nature

Click here to get full coverage on Belzutifan Demonstrates Durable Activity in VHL Disease Tumors - Vivek Narayan - UroToday

Belzutifan Demonstrates Durable Activity in VHL Disease Tumors - Vivek Narayan  UroToday

Belzutifan Demonstrates Durable Activity in VHL Disease Tumors - Vivek Narayan - UroToday

Click here to get full coverage on Belzutifan Demonstrates Promise in Von Hippel-Lindau Disease - Targeted Oncology

Belzutifan Demonstrates Promise in Von Hippel-Lindau Disease  Targeted Oncology

Belzutifan Demonstrates Promise in Von Hippel-Lindau Disease - Targeted Oncology

Click here to get full coverage on NY Islanders Daniil Prokhorov named VHL Rookie of the Month in Russia - Eyes On Isles

NY Islanders Daniil Prokhorov named VHL Rookie of the Month in Russia  Eyes On Isles

NY Islanders Daniil Prokhorov named VHL Rookie of the Month in Russia - Eyes On Isles

Click here to get full coverage on Reeling in a big scientific discovery - Harvard University

Reeling in a big scientific discovery  Harvard University

Reeling in a big scientific discovery - Harvard University

Click here to get full coverage on Belzutifan Displays Robust Activity in VHL-Associated RCC - OncLive

Belzutifan Displays Robust Activity in VHL-Associated RCC  OncLive

Belzutifan Displays Robust Activity in VHL-Associated RCC - OncLive

Click here to get full coverage on Drugit: crowd-sourcing molecular design of non-peptidic VHL binders - Nature

Drugit: crowd-sourcing molecular design of non-peptidic VHL binders  Nature

Drugit: crowd-sourcing molecular design of non-peptidic VHL binders - Nature

Click here to get full coverage on 'Grey's Anatomy' Features Rare Disease on Three-Episode Series - abcnews.com

'Grey's Anatomy' Features Rare Disease on Three-Episode Series  abcnews.com

'Grey's Anatomy' Features Rare Disease on Three-Episode Series - abcnews.com

Click here to get full coverage on Case Report: A familial hematological pedigree reveals VHL germline mutation as a principal predisposition factor with additional mutations modulating phenotypic heterogeneity - Frontiers

Case Report: A familial hematological pedigree reveals VHL germline mutation as a principal predisposition factor with additional mutations modulating phenotypic heterogeneity  Frontiers

Case Report: A familial hematological pedigree reveals VHL germline mutation as a principal predisposition factor with additional mutations modulating phenotypic heterogeneity - Frontiers

Click here to get full coverage on "Rasyad Wiratma digital footprint search.vhl" - Results on X | Live Posts & Updates - x.com

"Rasyad Wiratma digital footprint search.vhl" - Results on X | Live Posts & Updates  x.com

"Rasyad Wiratma digital footprint search.vhl" - Results on X | Live Posts & Updates - x.com

Click here to get full coverage on VHL Standings - Hockey/Russia - Flashscore.com

VHL Standings - Hockey/Russia  Flashscore.com

VHL Standings - Hockey/Russia - Flashscore.com

Click here to get full coverage on Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 5 - ACS Publications

Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 5  ACS Publications

Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 5 - ACS Publications

Click here to get full coverage on Belzutifan Approved for Tumors Linked to VHL - National Cancer Institute (.gov)

Belzutifan Approved for Tumors Linked to VHL  National Cancer Institute (.gov)

Belzutifan Approved for Tumors Linked to VHL - National Cancer Institute (.gov)

Click here to get full coverage on Maryam Soleimani’s Highlights from VIRO 2025 on VHL and Kidney Cancer - Oncodaily

Maryam Soleimani’s Highlights from VIRO 2025 on VHL and Kidney Cancer  Oncodaily

Maryam Soleimani’s Highlights from VIRO 2025 on VHL and Kidney Cancer - Oncodaily

Click here to get full coverage on When Can We Expect A Profit From Vitasora Health Limited (ASX:VHL)? - simplywall.st

When Can We Expect A Profit From Vitasora Health Limited (ASX:VHL)?  simplywall.st

When Can We Expect A Profit From Vitasora Health Limited (ASX:VHL)? - simplywall.st

Click here to get full coverage on Saturation genome editing maps the functional spectrum of pathogenic VHL alleles - Nature

Saturation genome editing maps the functional spectrum of pathogenic VHL alleles  Nature

Saturation genome editing maps the functional spectrum of pathogenic VHL alleles - Nature

Click here to get full coverage on Penn Medicine at the 2025 ASCO Annual Meeting - Penn Medicine

Penn Medicine at the 2025 ASCO Annual Meeting  Penn Medicine

Penn Medicine at the 2025 ASCO Annual Meeting - Penn Medicine

Click here to get full coverage on France’s HAS Grants Post-MA Early Access for MSD’s Welireg in VHL-Associated Localized Tumors - NAVLIN DAILY

France’s HAS Grants Post-MA Early Access for MSD’s Welireg in VHL-Associated Localized Tumors  NAVLIN DAILY

France’s HAS Grants Post-MA Early Access for MSD’s Welireg in VHL-Associated Localized Tumors - NAVLIN DAILY

Click here to get full coverage on VHL Stock Price and Chart — ASX:VHL - TradingView

VHL Stock Price and Chart — ASX:VHL  TradingView

VHL Stock Price and Chart — ASX:VHL - TradingView

Click here to get full coverage on VHL suppresses UBE3B-mediated breast tumor growth and metastasis - Nature

VHL suppresses UBE3B-mediated breast tumor growth and metastasis  Nature

VHL suppresses UBE3B-mediated breast tumor growth and metastasis - Nature

Click here to get full coverage on European Commission Approves Belzutifan for VHL Disease–Associated Tumors, Advanced ccRCC - OncLive

European Commission Approves Belzutifan for VHL Disease–Associated Tumors, Advanced ccRCC  OncLive

European Commission Approves Belzutifan for VHL Disease–Associated Tumors, Advanced ccRCC - OncLive

Click here to get full coverage on LA Kings Sign Defenseman Kirill Kirsanov To a Two-Year Entry-Level Contract | Los Angeles Kings - NHL.com

LA Kings Sign Defenseman Kirill Kirsanov To a Two-Year Entry-Level Contract | Los Angeles Kings  NHL.com

LA Kings Sign Defenseman Kirill Kirsanov To a Two-Year Entry-Level Contract | Los Angeles Kings - NHL.com

Click here to get full coverage on A ‘game-changer’ for von Hippel-Lindau disease treatment - UT MD Anderson

A ‘game-changer’ for von Hippel-Lindau disease treatment  UT MD Anderson

A ‘game-changer’ for von Hippel-Lindau disease treatment - UT MD Anderson

Click here to get full coverage on VHL mosaicism: the added value of multi-tissue analysis - Nature

VHL mosaicism: the added value of multi-tissue analysis  Nature

VHL mosaicism: the added value of multi-tissue analysis - Nature

Click here to get full coverage on Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease - Nature

Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease  Nature

Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease - Nature

Click here to get full coverage on (XB-VHL) PRIVATE Dassault Falcon 50 by Ricardo Mungarro - AeroXplorer

(XB-VHL) PRIVATE Dassault Falcon 50 by Ricardo Mungarro  AeroXplorer

(XB-VHL) PRIVATE Dassault Falcon 50 by Ricardo Mungarro - AeroXplorer

Click here to get full coverage on Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma - Nature

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma  Nature

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma - Nature

Click here to get full coverage on Zvezda vs Izhstal scores & predictions - Sofascore

Zvezda vs Izhstal scores & predictions  Sofascore

Zvezda vs Izhstal scores & predictions - Sofascore

Click here to get full coverage on VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma - Nature

VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma  Nature

VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma - Nature

Click here to get full coverage on Zvezda vs Norilsk scores & predictions - Sofascore

Zvezda vs Norilsk scores & predictions  Sofascore

Zvezda vs Norilsk scores & predictions - Sofascore

Click here to get full coverage on Yuzhny Ural vs Chelmet scores & predictions - Sofascore

Yuzhny Ural vs Chelmet scores & predictions  Sofascore

Yuzhny Ural vs Chelmet scores & predictions - Sofascore

Click here to get full coverage on Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC | Communications Biology - Nature

Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC | Communications Biology  Nature

Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC | Communications Biology - Nature

Click here to get full coverage on CRISPR-Cas9 genetic screens reveal regulation of TMPRSS2 by the Elongin BC-VHL complex - Nature

CRISPR-Cas9 genetic screens reveal regulation of TMPRSS2 by the Elongin BC-VHL complex  Nature

CRISPR-Cas9 genetic screens reveal regulation of TMPRSS2 by the Elongin BC-VHL complex - Nature

Click here to get full coverage on Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease - The New England Journal of Medicine

Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease  The New England Journal of Medicine

Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease - The New England Journal of Medicine

Click here to get full coverage on Effects of Germline VHL Deficiency on Growth, Metabolism, and Mitochondria - The New England Journal of Medicine

Effects of Germline VHL Deficiency on Growth, Metabolism, and Mitochondria  The New England Journal of Medicine

Effects of Germline VHL Deficiency on Growth, Metabolism, and Mitochondria - The New England Journal of Medicine

Click here to get full coverage on Changing the Life of a Patient with von Hippel-Lindau Syndrome - National Cancer Institute (.gov)

Changing the Life of a Patient with von Hippel-Lindau Syndrome  National Cancer Institute (.gov)

VHL

Price Chart

Key Statistics

Technicals

About VHL

Latest News

Vegas Golden Knights Sign Goaltender Pavel Moysevich to Three-Year, Entry-Level Contract - NHL.com

Networks in action: strategic milestones of BIREME, VHL and RIPSA in March - Pan American Health Organization (PAHO)

VHL: Revenue growth accelerates through US expansion, EMR efficiencies, and stacked reimbursement - TradingView

Advanced Charts

Top Gainers

Top Losers